Zheng, D., Lin, X., Gao, X., Wang, L., Zhu, M. · Journal of Psychosomatic Research · 2025
Pooling 10 RCTs (774 patients: 388 EFT, 386 control), EFT significantly reduced depression (MD=-7.41, 95% CI -9.32 to -5.51, p<.001) and anxiety (MD=-7.92, 95% CI -11.01 to -4.83, p<.001) and improved sleep quality (MD=-1.96, 95% CI -2.80 to -1.13, p<.001); for anticipatory grief, EFT improved sadness, anger, death attitude, somatic symptoms, religious comfort, and perceived social support, but showed no significant effect on disease adjustment, self-awareness, or psychological distress.
This is 10 pooled randomized trials and nearly 800 patients converging on real reductions in depression and anxiety and better sleep in people with cancer — not one small study that could be a fluke, but a weight-of-evidence signal that's hard to dismiss, arriving exactly where psychological distress is known to affect treatment adherence and quality of life.
Imagine someone newly diagnosed with cancer, exhausted by hospital visits, whose anxiety and sleepless nights compound the physical toll of treatment. Because tapping is done by the patient alone, with no clinician needed once it's learned, if these pooled findings continue to hold up it could become a low-cost tool oncology wards hand patients alongside existing care — something to use quietly in a waiting room or at 3 a.m. when panic sets in, with no nurse call button required. It's easy to imagine cancer support nonprofits training volunteers to teach it to patients whose insurance won't cover extra counseling.
With this pooled signal on depression, anxiety, and sleep, the natural next step is a biomarker-anchored oncology trial: does the drop in depression and anxiety track with lower cortisol and lower inflammatory cytokines (IL-6, CRP, TNF-alpha) that run high in cancer-related fatigue and are linked to prognosis, and does actigraphy confirm the sleep gains objectively? It would also be worth testing EFT layered onto standard oncology psychosocial care, and following patients well past active treatment to see if the gains hold through survivorship.
| Design | Meta-analysis |
|---|---|
| Participants | 774 people |
| Population | people with cancer across 10 pooled randomized controlled trials |
| Comparison group | various (routine care/waitlist across pooled trials) |
| Effect size | Mean Difference = -7.41 (95% CI -9.32 to -5.51) — on depression symptoms, EFT vs control (between-group) |
| Outcome measures | depression, anxiety, anticipatory grief (sadness, anger, death attitude, somatic symptoms, religious comfort, perceived social support, disease adjustment, self-awareness, psychological distress), sleep quality |
| Journal | Journal of Psychosomatic Research |
| Year | 2025 |
| Country | China |
| Language | English |
| Method | EFT / tapping |
| Publication type | Review or meta-analysis |
| Verification | ✓ Confirmed against the primary source |
Zheng, D., Lin, X., Gao, X., Wang, L., & Zhu, M. (2025). The impact of emotional freedom techniques on anxiety, depression, and anticipatory grief in people with cancer: A meta-analysis and systematic review. Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2025.112088
This record is part of the Tapping Evidence Base — an openly-sourced, fully-referenced directory of the research on EFT/tapping. Explore more studies on Cancer & Serious Illness
A ready-made graphic — right-click or long-press to save the image.